Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients

Br J Dermatol. 2017 Oct;177(4):901-902. doi: 10.1111/bjd.15886.

Authors

M O Nguyen^{1

2}, H T Nguyen³, M M Asgari^{1

2}

Affiliations

¹ Department of Dermatology, Massachusetts General Hospital, 50 Staniford Street, Suite 230A, Boston, MA, 02114, U.S.A.
² Department of Population Medicine, Harvard Medical School, Boston, MA, U.S.A.
³ Division of Psychiatric Genomics, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, NYC, NY, U.S.A.

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Squamous Cell
Humans
Organ Transplantation
Precision Medicine*
Risk
Skin Neoplasms
Transplant Recipients*

Grants and funding